Search Results - James C. Yang

Refine Results
  1. 1
    Toxicities Associated With Adoptive T-Cell Transfer for Cancer

    Toxicities Associated With Adoptive T-Cell Transfer for Cancer by James C. Yang

    Published 2015
    Get full text
    Revisão
    Save to List
    Saved in:
  2. 2
    Adoptive T-Cell Therapy for Cancer

    Adoptive T-Cell Therapy for Cancer by James C. Yang, Steven A. Rosenberg

    Published 2016
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Lifileucel: FDA-approved T-cell therapy for melanoma

    Lifileucel: FDA-approved T-cell therapy for melanoma by Mei Li M. Kwong, James C. Yang

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells.

    The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic act... by James J. Mulé, James C. Yang, S Shu, S A Rosenberg

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Cancer immunotherapy: moving beyond current vaccines

    Cancer immunotherapy: moving beyond current vaccines by Steven A. Rosenberg, James C. Yang, Nicholas P. Restifo

    Published 2004
    Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells.

    Cytolytic and biochemical properties of cytoplasmic granules of murine lymphokine-activated killer cells. by Pierre A. Henkart, Chongkang Yue, James C. Yang, S A Rosenberg

    Published 1986
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy

    High Avidity CTLs for Two Self-Antigens Demonstrate Superior In Vitro and In Vivo Antitumor Efficacy by Herbert J. Zeh, Donna Perry-Lalley, Mark E. Dudley, Steven A. Rosenberg, James C. Yang

    Published 1999
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Adoptive cell transfer: a clinical path to effective cancer immunotherapy

    Adoptive cell transfer: a clinical path to effective cancer immunotherapy by Steven A. Rosenberg, Nicholas P. Restifo, James C. Yang, Richard A. Morgan, Mark E. Dudley

    Published 2008
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors

    Identification of T-cell Receptors Targeting KRAS-Mutated Human Tumors by Qiong J. Wang, Zhiya Yu, Kayla Griffith, Ken‐ichi Hanada, Nicholas P. Restifo, James C. Yang

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2

    Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2 by Richard A. Morgan, James C. Yang, Mio Kitano, Mark E. Dudley, Carolyn M. Laurençot, Steven A. Rosenberg

    Published 2010
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes

    Expression profiling of TCR-engineered T cells demonstrates overexpression of multiple inhibitory receptors in persisting lymphocytes by Daniel Abate‐Daga, Ken‐ichi Hanada, Jeremy L. Davis, James C. Yang, Steven A. Rosenberg, Richard A. Morgan

    Published 2013
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells

    Selection of CD8+PD-1+ Lymphocytes in Fresh Human Melanomas Enriches for Tumor-reactive T Cells by Takashi Inozume, Ken‐ichi Hanada, Qiong J. Wang, Mojgan Ahmadzadeh, John R. Wunderlich, Steven A. Rosenberg, James C. Yang

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Pathways and therapeutic targets in melanoma

    Pathways and therapeutic targets in melanoma by Emma Shtivelman, Michael A. Davies, Patrick Hwu, James C. Yang, Michal Lotem, Moshe Oren, Keith T. Flaherty, David E. Fisher

    Published 2014
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  14. 14
    Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers

    Preclinical Evaluation of Chimeric Antigen Receptors Targeting CD70-Expressing Cancers by Qiong J. Wang, Zhiya Yu, Ken‐ichi Hanada, Krishna Patel, David E. Kleiner, Nicholas P. Restifo, James C. Yang

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity<i>In Vivo:</i>Role of Immune Cell Subpopulations

    RANTES Secretion by Gene-Modified Tumor Cells Results in Loss of Tumorigenicity<i>In Vivo:</i>Role of Immune Cell Subpopulations by James J. Mulé, Mary Custer, Bruce J. Averbook, James C. Yang, Jeffrey S. Weber, David V. Goeddel, Steven A. Rosenberg, Thomas J. Schall

    Published 1996
    Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells

    Induction of CD4+ T cell–dependent antitumor immunity by TAT-mediated tumor antigen delivery into dendritic cells by Helen Y. Wang, Tihui Fu, Gang Wang, Gang Zeng, Donna Perry-Lalley, James C. Yang, Nicholas P. Restifo, Patrick Hwu, Rongfu Wang

    Published 2002
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy

    Long-Term Follow-Up of Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy by Kathryn M. Cappell, Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre, Steven A. Rosenberg, James N. Kochenderfer

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

    Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma by Richard E. Royal, Catherine Lévy, Keli Turner, Aarti Mathur, Marybeth S. Hughes, Udai S. Kammula, Richard M. Sherry, Suzanne L. Topalian, James C. Yang, Israel Lowy, Steven A. Rosenberg

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    An antigenic peptide produced by reverse splicing and double asparagine deamidation

    An antigenic peptide produced by reverse splicing and double asparagine deamidation by Alexandre Dalet, Paul F. Robbins, Vincent Stroobant, Nathalie Vigneron, Yong F. Li, Mona El‐Gamil, Ken‐ichi Hanada, James C. Yang, Steven A. Rosenberg, Benoı̂t J. Van den Eynde

    Published 2011
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL

    Tumor Infiltrating Lymphocyte Therapy for Metastatic Melanoma: Analysis of Tumors Resected for TIL by Stephanie L. Goff, Franz O. Smith, Jacob A. Klapper, Richard M. Sherry, John R. Wunderlich, Seth M. Steinberg, Donald White, Steven A. Rosenberg, Mark E. Dudley, James C. Yang

    Published 2010
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: